Dose optimisation and intensification of cytotoxics in solid tumours supported by haematopoietic growth factors
- 1 January 1994
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 30 (3) , 410-412
- https://doi.org/10.1016/0959-8049(94)90267-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung CancerNew England Journal of Medicine, 1993
- Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumorsAnnals of Oncology, 1993
- Dose intensity of initial chemotherapy may have an impact on survival in limited small cell lung carcinomaLung Cancer, 1993
- Accelerated chemotherapy with or without GM-CSF for small cell lung cancer: a non-randomised pilot studyEuropean Journal of Cancer and Clinical Oncology, 1990
- The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancerBritish Journal of Cancer, 1989
- Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Chemotherapy-Induced MyelosuppressionNew England Journal of Medicine, 1988
- More is better.Journal of Clinical Oncology, 1988
- Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the UrotheliumNew England Journal of Medicine, 1988
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982
- Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute LeukemiaAnnals of Internal Medicine, 1966